# Sources — Billie Holiday

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 3, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. “Billie Holiday: About the Performer.” PBS *American Masters* (WNET). Supports her birth as Eleanora Fagan on April 7, 1915; that her heroin addiction became severe in the late 1940s, after her mother’s death, and that she was repeatedly arrested over her heroin use in that period; that she checked herself into an institution in the hope of breaking her habit; that in 1950 she was denied a license to perform in establishments that sold alcohol; that she slipped deeper into alcoholism over the following seven years; and her death on July 17, 1959, at 44. https://www.pbs.org/wnet/americanmasters/billie-holiday-about-the-performer/68/
2. Biography.com Editors. “Billie Holiday.” Biography.com, April 3, 2014, updated November 12, 2021. Supports her birth in Philadelphia; that she began using heroin in the early 1940s; that after her mother’s death in October 1945 she drank more heavily and her drug use increased; her arrest and conviction for narcotics possession in 1947 and a sentence of a year and a day; the autobiography *Lady Sings the Blues* (1956), written in collaboration with William Dufty; her admission to the hospital for heart and liver problems after her last performance and her arrest for possession while in the hospital; and her death on July 17, 1959. https://www.biography.com/musicians/billie-holiday
3. “Billie Holiday Historical Marker.” Clio, African American History of Philadelphia Heritage Trail (Saint Vincent College), May 2021. Supports her birth in Philadelphia and upbringing in Baltimore by her mother, Sarah Julia “Sadie” Fagan; her arrest on May 16, 1947, her guilty plea, her sentence at the Alderson federal facility in West Virginia, and the loss of her cabaret card; her early release on March 16, 1948; the diagnosis of cirrhosis in 1959 and treatment at Metropolitan Hospital; the raid on her hospital room and the police guard; and her death on July 17, 1959, from pulmonary edema and heart failure. https://theclio.com/tour/714/4
4. Nicholson S. “Holiday, Billie.” Jazz.com encyclopedia. Supports her birth registration in Philadelphia on April 7, 1915; her mother’s death on October 6, 1945; her heroin addiction during 1943 and 1944; her arrest after a week at the Earle Theatre in Philadelphia on May 16, 1947, the sentence of a year and a day, and custody until March 16, 1948; the denial of a cabaret card; and the “ghosted” autobiography of 1956. It dates her death to July 15, 1959 and names the facility “Alderston, Virginia” (see the editorial resolutions). https://jazz.com/encyclopedia/holiday-billie
5. Chang R. “Billie Holiday and the U.S. government’s war on narcotics.” Biography.com. Supports only the retrospective account that the Federal Bureau of Narcotics pursued her for years, that later writers attribute this to racism, and that it is linked to her performance of “Strange Fruit.” https://www.biography.com/musicians/billie-holiday-narcotics-us-government
6. Adams J. “Lady Day departs into that good night.” *The Globe and Mail*, July 17, 2014. Supports her admission to Metropolitan Hospital in East Harlem in late May 1959, her arrest in the hospital for narcotics possession, the police officer outside her room, and the cause of death as cirrhosis of the liver and pulmonary edema. https://www.theglobeandmail.com/multimedia/lady-day-departs-into-that-good-night/article19633469
7. HISTMED Master Roster v3. Internal project source. Its clinical claims were provisional and were not treated as independent corroboration.

## Clinical guidance

1. The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update. *Journal of Addiction Medicine* 2020 (PMID 32511106). Buprenorphine starts without withdrawal after enforced abstinence, dosing to 16 mg or more, naloxone, urine drug testing, the prescription drug monitoring program, psychosocial treatment not as a condition of medication, pain management on buprenorphine, pregnancy, and continuing treatment through a return to use. https://pubmed.ncbi.nlm.nih.gov/32511106/
2. Substance Abuse and Mental Health Services Administration. Treatment Options for Substance Use Disorder (buprenorphine, methadone, naltrexone, acamprosate, and disulfiram). https://www.samhsa.gov/medications-substance-use-disorders
3. VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021). Acamprosate, naltrexone, and topiramate for alcohol use disorder; withdrawal risk; hepatitis and HIV testing; recovery support. https://www.healthquality.va.gov/guidelines/MH/sud/
4. Crabb DW, et al. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. *Hepatology* 2020 (PMID 31314133). https://pubmed.ncbi.nlm.nih.gov/31314133/
5. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. *Hepatology* 2025 (PMID 38489523). FIB-4 below 1.3 as low risk; elastography when FIB-4 is 1.3 or higher. https://pubmed.ncbi.nlm.nih.gov/38489523/
6. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), depression, bipolar, and mood disorders monograph. PHQ-9 measurement, suicide-risk reassessment, and the MDQ at a new depressive episode. https://patrickrutledge.github.io/topthirty/
7. VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024). https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/srb/index.asp
8. Centers for Disease Control and Prevention. Screening and Testing for Hepatitis B Virus Infection, 2023 (https://pubmed.ncbi.nlm.nih.gov/36893044/) and the Adult Immunization Schedule by Medical Condition and Other Indication (https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html).
9. American Dental Association. Evidence-based clinical practice guideline on antibiotic use for the urgent management of pulpal- and periapical-related dental pain and intraoral swelling. *J Am Dent Assoc* 2019 (PMID 31668170). https://pubmed.ncbi.nlm.nih.gov/31668170/
10. U.S. Preventive Services Task Force: depression and suicide risk (2023), hepatitis C (2020), HIV (2019), cervical cancer (2024), chlamydia and gonorrhea (2021), tobacco cessation (2021), unhealthy alcohol use (2018), intimate partner violence (2018), and the A and B recommendations. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
11. Medicare Preventive Services reference (Aether Forge, 2026). https://patrickrutledge.github.io/preventative_services/

## Editorial resolutions

- **Recent-death rule.** Holiday died in 1959, so the rule does not apply. Every historical claim is still limited to what the six fetched sources state.
- **Index age.** The index visit on April 20, 2026 maps to April 20, 1948, when she was 33, five weeks after her early release from federal custody on March 16, 1948. The synthetic date of birth is April 7, 1993 (shift 78 years). The chronic-care visits on April 27, May 26, July 20, and October 19, 2026, the preventive visit on August 31, 2026, and the sick visit on September 21, 2026 map to the same days of 1948, before her next documented arrest. Past medical history and family history include only events before the index date. The index was chosen because the weeks after release from custody carry the highest overdose risk, which makes medication for opioid use disorder and naloxone the central teaching point.
- **Liver disease.** Cirrhosis is documented only in her final year, eleven years after the episode. Liver disease is therefore kept out of the problem list. The episode screens: liver tests, PEth, FIB-4 (1.18 at intake, 0.78 at six months), hepatitis C, hepatitis B, and HIV tests, and hepatitis A and B vaccines. The AST, GGT, and MCV elevations at intake are synthetic findings of heavy drinking, not a claim about her real liver.
- **Arrests and targeting.** The arrests, the guilty plea, the sentence, and the loss of her cabaret card are documented (**D**) and are recorded as history, without judgment and never as evidence of her character. The account that the narcotics bureau’s pursuit of her was racially motivated comes from later writers and is graded **R** with certainty probable; the record states no person’s motives as fact and names no official. In the visit notes it appears only as her experience of being singled out by law enforcement, which shapes a trauma-informed, confidential approach. The custody facility is named Alderson, West Virginia, as in Clio; the Jazz.com entry’s “Alderston, Virginia” is treated as an error.
- **Death date.** PBS *American Masters*, Biography.com, and Clio give July 17, 1959; the Jazz.com entry gives July 15. July 17 is preferred and July 15 recorded as a conflicting alternative. The cause is given as cirrhosis with pulmonary edema (The Globe and Mail) or pulmonary edema and heart failure (Clio); both are recorded in CLM-0009 without detail.
- **Problems.** Opioid use disorder is coded F11.20 (opioid dependence, uncomplicated), with the display recording early remission in a controlled environment at intake; the code does not change with the return to use. Alcohol use disorder is coded F10.20. Both are both_with_link to the documented history and trigger the structured safety assessment, which records no suicidal ideation, gives the 988 Suicide & Crisis Lifeline, adds overdose prevention, and is reviewed at every later visit. A periapical abscess (K04.7) is added at the sick visit and resolved.
- **Non-linear recovery.** Following the integrated recovery approach of the project’s alcohol-and-trauma pilot record, the three-month visit follows a brief return to heroin use caused by a gap in her medication (a lapsed prior authorization on tour). It is managed without blame, discharge, or a change in her place in treatment: buprenorphine continues, support increases, and the cause is fixed. Her own documented wish to recover (CLM-0005) is the anchor for her engagement.
- **Person-first language.** The record says “opioid use disorder,” “return to use,” “person who uses drugs,” and “urine drug test,” not “addict,” “relapse” as a moral failure, “clean,” or “dirty.” Urine testing is described as part of care, never as a test of trust or a condition of treatment.
- **Quotations.** Her autobiography and her own published words were not fetched, so nothing is quoted from her or attributed to her. No statement, decision, or health fact is attributed to any other real person; William Dufty is named only as co-author of the autobiography in CLM-0008, and her mother appears only in the family history and the claims.
- **Synthetic content.** All visits, laboratory values, vital signs, PEth, PHQ-9, AUDIT-C, and DAST-10 scores, the urine drug test results, the medicines and doses, her tobacco use, her friend and peer recovery coach, the tour details, the dental abscess, and her height (165 cm) are synthetic. Qualitative results (hepatitis B surface antigen and core antibody, HIV antigen-antibody, pregnancy test, urine drug tests, and the sexual-health and cervical screening ordered at the preventive visit) appear only in the note text, because the schema stores numeric results; the cervical and sexual-health results are not reported.
- **Preventive visit.** A periodic adult preventive visit (CPT 99395 with 99497 in plain text) was added at age 33. Judgment calls: cervical, chlamydia, gonorrhea, and syphilis tests are ordered with no results recorded; tobacco cessation and the HPV vaccine are recorded as declined; advance care planning names an unnamed health care agent and records only general priorities.
- **Sick visit.** A same-day visit for a periapical abscess was added three weeks after the preventive visit found untreated decay. It teaches acute pain care for a person on buprenorphine: buprenorphine continues unchanged, ibuprofen with acetaminophen is used instead of an opioid, acetaminophen is limited to 3,000 mg a day because of alcohol use, amoxicillin is given because of swelling and a low-grade temperature per the ADA guideline, and dental drainage is arranged. The infection is synthetic and implies no real diagnosis.
- **Focused visits.** The four chronic-care follow-ups (one week, five weeks, three months, and six months) are documented as focused visits on the ASAM and SAMHSA guidance for opioid use disorder, the VA/DoD guideline for alcohol use disorder, the AASLD liver guidance, the CMID depression monograph, and the VA/DoD suicide-risk guideline. Protocol deviation recorded instead of invented results: after the one-week visit, the next contact was four weeks later because she was on tour, longer than the one to two weeks advised in the first month; weekly counseling calls continued, no harm resulted, and video check-ins every two weeks were added. The PHQ-9 of 11 at three months was assessed by interview, with no depressive episode found and the MDQ marked not indicated, and was 6 at the preventive visit and 4 at six months.
- **Consultation.** The addiction medicine referral and the consultation by Julian Ortiz, MD (a fictional consultant), on the day of the one-week visit, are **S**. The consultant answers the five referral questions in line with what the record shows afterwards: buprenorphine increased to 16 mg that day, acamprosate started, FIB-4 enough without elastography, testing and visit frequency as recorded (including the deviation), and continued treatment through the return to use with a supply plan for touring. Extended-release buprenorphine was offered after the return to use, and she chose to stay on films.
- **Not used.** Her autobiography, court and prison files, FBI or narcotics bureau files, and biographies were not fetched and are not used. Accounts naming the officials involved, the details of the 1949 arrest, and accounts of withdrawal treatment in her final hospital stay are not used.
